Skip to Content

Cannabis Strategic Ventures NUGS

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

NUGS is trading at a 241% premium.
Price
$0.00
Fair Value
$6.00
Uncertainty
Extreme
1-Star Price
$4.49
5-Star Price
$8.57
Economic Moat
Nyck
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NUGS is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.01
Bid/Ask
$0.00 / $0.01
Market Cap
$368.43
Volume/Avg
1,000 / 155,436

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Cannabis Strategic Ventures focuses on the medical and legal recreational cannabis sector. It provides temporary, permanent, and long-term staffing solutions, employment and human resources consulting to the legal Cannabis sector.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Total Number of Employees

Valuation

Metric
NUGS
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
NUGS

Financial Strength

Metric
NUGS
Quick Ratio
0.09
Current Ratio
0.27
Interest Coverage
−163.31
Quick Ratio
NUGS

Profitability

Metric
NUGS
Return on Assets (Normalized)
−45.08%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
−50.51%
Return on Assets
NUGS
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
YbjdrcwcTqlrn$82.1 Bil
Merck KGaA ADR
MKKGY
YczsgvqvTmzgwq$75.2 Bil
Haleon PLC ADR
HLN
DfmxdgjQdfyg$41.4 Bil
Viatris Inc
VTRS
HwqlvpzyyPdyhv$14.4 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
PyystzdvzMyn$13.7 Bil
Catalent Inc
CTLT
GfwrdprLhnwvm$10.6 Bil
Perrigo Co PLC
PRGO
LwywlnwgWts$3.8 Bil
Prestige Consumer Healthcare Inc
PBH
ZrqyntcHhqnqt$3.5 Bil
Curaleaf Holdings Inc
CURLF
NcvdkpmscPrvl$3.0 Bil
Green Thumb Industries Inc
GTBIF
XwlxfhmqbsCtjv$2.7 Bil

Sponsor Center